Lilly and Amylin Get Divorced... anyone surprised?





































That's only because Wall St think Amylin are ripe for a takeover. Maybe Novo will buy them and shut them down for good.

Speaking of takeovers, why don't we just buy AMRI for $80M rather than use the rent-a-chemist scheme to pay inflated prices for professional labor?

Could someone please explain the "fuzzy math" of FIPNET on this one?